Learn / HELP
NASDAQ: HELP
Cybin (HELP) stock, explained like you're 5
Cybin trades on the Nasdaq under the ticker HELP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 862 million dollars.
- Ticker
- HELP
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 862 million dollars
Is Cybin a small, medium or large cap company?
No. Cybin is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 862 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Cybin makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves HELP stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- HELP Stock Gaps Higher, Then Fades, On $35 Barclays Target Ahead Of Q4 Psychedelic Drug Trial Results (Stocktwits)
- Cybin (HELP) Stock May Be Trading At A Premium Despite Fresh Depression Trial Data (Yahoo Finance)
- Election Day food drive to help stock shelves at Waterbury Common Market (Waterbury Roundabout)
- Cybin (NASDAQ:HELP) Stock Jumps 6.5% Here's Why (MarketBeat)
- A drug developer who helped secure FDA approvals is Helus Pharma’s board pick, pending Cboe Canada approval. (Stock Titan)
Follow HELP in your daily brief
Each trading day at 5 PM ET we post what happened to Cybin and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow HELP
Questions about Cybin stock
What does Cybin do?
Cybin trades on the Nasdaq under the ticker HELP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 862 million dollars.
What is the ticker symbol for Cybin?
Cybin trades under the ticker HELP on the Nasdaq.
What is Cybin's market cap?
Cybin is a small cap stock with a market cap of about 862 million dollars.
How does Cybin make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves HELP stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow HELP stock every day?
Add HELP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.